The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,259,423 in first-year total cost, median $190,476.
Most frequent study sections
- Career Development Study Section (J)[NCI-J]11
- Special Emphasis Panel[ZCA1 RTRB-4 (O1)]1
Most frequent institutions
- WASHINGTON UNIVERSITY2
- BRIGHAM AND WOMEN'S HOSPITAL1
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- JOHNS HOPKINS UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Loss of Cell Identity as a Prerequisite for Breast Cancer Development1K22CA266533-01 | MARTINEZ ZAMUDIO, RICARDO IVAN | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $194,682 | NCI |
| 2023 | Deep Sequencing of Relapse and Refractory Hodgkin Lymphoma Genomes: A Study of Tumor Biology and Evolution1K22CA266743-01 | GOMEZ, FELICIA | WASHINGTON UNIVERSITY, MO | $194,476 | NCI |
| 2023 | Investigating IQGAP1, a scaffold protein, in liver biology and Hepatocellular Carcinoma to overcome barriers in in vivo models1K22CA258677-01A1 | DELGADO, EVAN R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $179,793 | NCI |
| 2022 | Identification of therapeutic vulnerabilities in prostate cancer bone metastasis1K22CA258806-01 | ARRIAGA, JUAN MARTIN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $192,456 | NCI |
| 2022 | Elucidating the role of Ybx1 in cerebellar development and medulloblastoma1K22CA262343-01 | EVANS, MYRON K | SEATTLE CHILDREN'S HOSPITAL, WA | $187,056 | NCI |
| 2021 | Imaging zinc secretion from the exocrine pancreas for the early diagnosis of pancreatic adenocarcinoma with MRI1K22CA241387-01A1 | CLAVIJO JORDAN, MARIA VERONICA | MASSACHUSETTS GENERAL HOSPITAL, MA | $199,788 | NCI |
| 2020 | TERT transcriptional deregulation in thyroid cancer progression1K22CA230381-01A1 | LANDA-LOPEZ, INIGO | BRIGHAM AND WOMEN'S HOSPITAL, MA | $196,150 | NCI |
| 2020 | Understanding the regulatory role and therapeutic potential of long non-coding RNAs in metastatic colorectal cancer1K22CA241329-01 | SILVA-FISHER, JESSICA | WASHINGTON UNIVERSITY, MO | $188,496 | NCI |
| 2020 | Uncovering the molecular networks underlying non-genetic heterogeneity in cancer cell populations1K22CA237857-01A1 | HARRIS, LEONARD ALFREDO L. | UNIVERSITY OF ARKANSAS AT FAYETTEVILLE, AR | $187,596 | NCI |
| 2020 | Defining the DNA damage pathway in faithful mitotic progression1K22CA244865-01 | KABECHE, LILIAN CAROLINA | YALE UNIVERSITY, CT | $186,192 | ZCA1 |
| 2019 | Identification of Novel Gene Regulatory Interactions Driving the Immune Evasion Program Through Transcriptional Activation of CD47 in Cancer1K22CA226365-01A1 | BETANCUR, PAOLA A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $199,098 | NCI |
| 2019 | Targeting M2-Tumor Associated Macrophages to overcome tumor immunity in metastatic castration-resistant prostate cancer1K22CA237623-01 | ZARIF, JELANI CHINELO | JOHNS HOPKINS UNIVERSITY, MD | $153,640 | NCI |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.